Abstract
The transforming growth factor-βs are potent growth inhibitors of normal and transformed breast epithelial cells in culture. In vivo, these peptides modulate the development of the mouse mammary gland. Tissue-specific overexpression of mature TGF-β1 in transgenic mice results in mammary gland atrophy and prevention of carcinogen-induced breast tumorigenesis. However, the inhibitory effect of endogenous or exogenous TGF-βs on established tumor cells is less clear. Several published circumstantial and more direct data argue that, in some cases, the tumor cell TGF-βs may contribute to the maintenance and/or progression of tumor cells in an intact host by modulating their interaction with host factors. This differential role of the TGF-βs on mammary cells as determined by their normal or transformed phenotype as well as the biological and clinical implications of these data are discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 49-56 |
Number of pages | 8 |
Journal | Breast Cancer Research and Treatment |
Volume | 38 |
Issue number | 1 |
DOIs | |
State | Published - 1996 |
Keywords
- Breast carcinoma
- Mammary epithelium
- Natural killer activity
- Transforming growth factor-βs
ASJC Scopus subject areas
- Oncology
- Cancer Research